Companion Animals

Radioiodine Treatment for Feline Hyperthyroidism: Welfare Benefits and Considerations

Radioiodine (I-131) therapy is the gold-standard curative treatment for feline hyperthyroidism. Understanding its welfare benefits and the isolation requirements it involves helps owners make informed decisions for their cats.

Key Facts

Welfare Considerations

Radioiodine treatment represents a significant welfare improvement for hyperthyroid cats compared to lifelong medication — achieving permanent cure with a single procedure. The welfare costs are concentrated in the isolation period: cats that are strongly human-bonded or anxious may find 1-3 weeks of hospital isolation or restricted home contact genuinely distressing. However, this short-term welfare cost must be weighed against the long-term benefit: elimination of the chronic suffering associated with untreated or incompletely controlled hyperthyroidism (weight loss, muscle wasting, heart disease, hypertension). Providing familiar bedding, toys, and recorded owner voices during isolation can mitigate stress. Facilities that allow some supervised owner visits during isolation have better welfare outcomes for anxious cats.

What You Can Do